Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
- PMID: 20500848
- PMCID: PMC2894023
- DOI: 10.1186/1824-7288-36-39
Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
Abstract
Background: In beta-thalassemia, profound anemia and severe hemosiderosis cause functional and physiological abnormalities in various organ systems. In recent years, there have been few published studies mainly in adult demonstrating renal involvement in beta-thalassemia. This prospective study was aimed to investigate renal involvement in pediatric patients with transfusion dependent beta-thalassemia major (TD-betaTM), using both conventional and early markers of glomerular and tubular dysfunctions, and to correlate findings to oxidative stress and iron chelation therapy.
Methods: Sixty-nine TD-betaTM patients (aged 1-16 years) and 15 healthy controls (aged 3-14 years) were enrolled in this study. Based on receiving chelation therapy (deferoxamine, DFO), patients were divided into two groups: group [I] with chelation (n=34) and group [II] without chelation (n=35). Levels of creatinine (Cr), calcium (Ca), inorganic phosphorus (PO4), uric acid (UA) and albumin were measured by spectrophotometer. Serum (S) levels of cystatin-C (SCysC) and total antioxidant capacity (STAC) and urinary (U) levels of beta2-microglobulin (Ubeta2MG) were measured by immunosorbent assay (ELISA). Urinary N-acetyl-beta-D-glucosaminidase (UNAG) activity and malondialdehyde (UMDA) were measured by chemical methods. Estimated glomerular filtration rate (eGFR) was determined from serum creatinine.
Results: In patient with and without chelation, glomerular [elevated SCysC, SCr, Ualbumin/Cr and diminished eGFR]; and tubular dysfunctions [elevated SUA, SPO4, UNAG/Cr, Ubeta2MG/Cr] and oxidative stress marker disturbances [diminished STAC and elevated UMDA/Cr] were reported than controls. In patients with chelation, SCysC was significantly higher while, STAC was significantly lower than those without chelation. In all patients, SCysC showed significant positive correlation with SCr and negative correlation with eGFR; STAC showed significant positive correlation with eGFR and negative correlation with SCysC, SCr, UNAG/Cr; UMDA/Cr showed significant positive correlation with Ualbumin/Cr, Ubeta2MG/Cr, UNAG/Cr.
Conclusions: Our data confirm high frequency of glomerular and tubular dysfunctions in TD-betaTM pediatric patients which could be attributed to oxidative stress and DFO therapy.
Similar articles
-
Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.Acta Haematol. 2010;123(3):148-52. doi: 10.1159/000287238. Epub 2010 Feb 24. Acta Haematol. 2010. PMID: 20185899
-
Renal function and the oxidative status among children with thalassemia major and healthy controls: A cross-sectional study.Transfus Apher Sci. 2020 Aug;59(4):102746. doi: 10.1016/j.transci.2020.102746. Epub 2020 Feb 28. Transfus Apher Sci. 2020. PMID: 32173278
-
A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.Pediatr Hematol Oncol. 2013 Nov;30(8):748-54. doi: 10.3109/08880018.2013.823470. Pediatr Hematol Oncol. 2013. PMID: 24134694 Clinical Trial.
-
Biochemical Markers of Early Renal Dysfunction in Patients with β-thalassemia Major: A Systematic Review and Meta-analysis.Curr Med Chem. 2025;32(13):2572-2597. doi: 10.2174/0109298673250805230922054406. Curr Med Chem. 2025. PMID: 37921173
-
Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.Semin Hematol. 1995 Oct;32(4):304-12. Semin Hematol. 1995. PMID: 8560288 Review.
Cited by
-
Genetic Variation Impacts in Patients with Major Beta-Thalassemia.Iran J Public Health. 2015 May;44(5):722-3. Iran J Public Health. 2015. PMID: 26284222 Free PMC article. No abstract available.
-
Role of serum cystatin-C and beta-2 microglobulin as early markers of renal dysfunction in children with beta thalassemia major.Int J Nephrol Renovasc Dis. 2017 Sep 11;10:261-268. doi: 10.2147/IJNRD.S142824. eCollection 2017. Int J Nephrol Renovasc Dis. 2017. PMID: 28979155 Free PMC article.
-
Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major.Children (Basel). 2021 Feb 3;8(2):100. doi: 10.3390/children8020100. Children (Basel). 2021. PMID: 33546213 Free PMC article.
-
Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia.Cureus. 2022 Sep 15;14(9):e29183. doi: 10.7759/cureus.29183. eCollection 2022 Sep. Cureus. 2022. PMID: 36258980 Free PMC article.
-
β-Thalassemia minor & renal tubular dysfunction: is there any association?BMC Nephrol. 2021 Dec 7;22(1):404. doi: 10.1186/s12882-021-02602-9. BMC Nephrol. 2021. PMID: 34872508 Free PMC article.
References
-
- Shehab M, Barakat AY. Thalassemia B with distal renal tubular acidosis: a previously undescribed association. Int J Pediatr Nephrol. 1985;6:143–144. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous